Former Pfizer CEO Kindler joins Lux Capital
Aug 8 (Reuters) - Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.
Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.
Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.
- Tweet this
- Share this
- Digg this
The after-glow of Narendra Modi's election victory nearly four months ago is expected to have helped India's lumbering economy register its fastest growth in more than two years for the quarter ending in June. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article
Adani buys Australia coal mine royalty rights from Linc for $145 million Full Article